Design and synthesis of novel diosgenin-triazole hybrids targeting inflammation as potential neuroprotective agents.

Bioorganic & Medicinal Chemistry Letters
Yi HuangLei Ma

Abstract

Alzheimer's disease is a progressive neurodegenerative disease, and its incidence is expected to increase as the global population ages. Recent studies provide increasing evidence that inflammation plays a key role in the pathogenesis and progression of AD. Diosgenin, an active ingredient in Dioscorea nipponica Makino, is a promising bioactive lead compound in the treatment of Alzheimer's disease, which exhibited anti-inflammatory activity. To search for more efficient anti-Alzheimer agents, a series of novel diosgenin-triazolyl hybrids were designed, synthesized, and their neuroprotective effects against oxygen-glucose deprivation-induced neurotoxicity and LPS-induced NO production were evaluated. Most of these new hybrids displayed better activities than DIO. In particular, the promising compound L6 not only demonstrated an excellent neuroprotective effect but also showed the best anti-inflammatory activity. The structure-activity relationship study illustrated that the introduction of benzyl or phenyl triazole did improve the activity, and the introduction of benzyl triazole was better than that of phenyl triazole. The results we obtained showed that the diosgenin skeleton could be a promising structural template for the dev...Continue Reading

References

Aug 3, 2004·Journal of Neuroinflammation·Wolfgang J StreitW Sue T Griffin
Aug 8, 2014·Frontiers in Cellular Neuroscience·Juan Carlos MoralesChristian Bonansco
May 21, 2015·Nature Reviews. Neuroscience·Frank L HeppnerBurkhard Becher
Jul 19, 2015·Cold Spring Harbor Perspectives in Biology·Dorothy P Schafer, Beth Stevens
Nov 20, 2016·European Journal of Medicinal Chemistry·Zahra NajafiTahmineh Akbarzadeh
Dec 14, 2016·Annual Review of Physiology·Susanne A WolfHelmut Kettenmann
Jan 29, 2017·Metabolism: Clinical and Experimental·Theodore B VanItallie
Mar 4, 2017·Progress in Molecular Biology and Translational Science·S Pugazhenthi
Apr 27, 2017·Neuro-degenerative Diseases·Ricardo TaipaNuno Sousa
May 4, 2017·Journal of Neuroscience Research·Crystal AcostaChristopher M Anderson
Jun 18, 2017·International Immunopharmacology·Shaoxia WangLimin Hu
Aug 20, 2017·Journal of Neurology·Zhiyou CaiZhou Liu
Apr 11, 2018·European Journal of Medicinal Chemistry·Wenbao WangShaojiang Song
Dec 5, 2018·Bioorganic & Medicinal Chemistry Letters·Paul V FishPaul Whiting
Jan 5, 2019·ACS Chemical Neuroscience·Aparna Lakshmi ManchikalapudiAditya Sunkaria
Apr 8, 2019·Clinical Biochemistry·Tomris Ozben, Serkan Ozben
Jun 27, 2019·ACS Chemical Neuroscience·Keenan A WalkerReyhan Westbrook
Jul 11, 2019·Journal of Natural Products·Jou-Man HuangChia-Ron Yang
Jun 20, 2020·Journal of the Neurological Sciences·Md Sahab UddinGhulam Md Ashraf

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Related Papers

Future Journal of Pharmaceutical Sciences
Sachin KumarAkash Yadav
Yao xue xue bao = Acta pharmaceutica Sinica
Hong-Ping JiangJu-Zheng Fan
Lékařské listy
O SAHANEK, A BAJER
Yao xue xue bao = Acta pharmaceutica Sinica
L X Xu, A R Liu
© 2021 Meta ULC. All rights reserved